Dr. Scott Campell named CEO/Executive Director of FNIH
The Foundation for the National Institutes of Health (FNIH) named Dr. Scott Campbell as its new executive director and chief executive officer.
The FNIH is an independent non-profit organization established by Congress in 1990 that facilitates groundbreaking research at the NIH. Medical science is poised like never before to crack the code to some of humankind’s most vexing health challenges—including Alzheimer’s disease, HIV, malaria, and cancer. By supporting the mission of the National Institutes of Health (NIH), the Foundation for the National Institutes of Health draws together the world’s foremost researchers and resources, pressing the frontier to advance these critical discoveries.
Prior to joining the foundation, Dr. Campbell served as the national vice president of research programs at the American Diabetes Association (ADA) where he provided oversight to all research related programs at the ADA.
Campbell also provided input to the strategic planning efforts of the NIH National Center for Research Resources and the National Institute of Diabetes, Digestive and Kidney Disease. Internationally, he was the ADA Research Program liaison to the European Association for the Study of Diabetes (EASD) and the International Diabetes Federation (IDF). He continues to serve as a senior consultant to the China-America Institute of Diabetic Complications in the School of Pharmacy, Wenzhou Medical College.
"We are delighted Dr. Campbell will be at the helm of the foundation and, given his experience and background in biomedical, programmatic and donor development, are confident in his ability to take the organization to the next level," noted FNIH Chairman Dr. Charles A. Sanders.
"I am honored to serve as the new Executive Director of the foundation and look forward to working with the staff and colleagues of the foundation, NIH and the private sector to further the mission of NIH. In this era of scientific complexity, as research, development and health delivery costs continue to increase, efforts at making the critical scientific advances needed to improve public health in the U.S., and globally, require collaboration between the public and private sectors. I will look for new and creative ways to fulfill the mission of the foundation," said Campbell.
Campbell received his Ph.D. in Basic Biomedical Sciences in 1985 from the University of South Florida. Following postdoctoral training in cardiovascular physiology at the University of Ottawa in Canada, he spent 12 years in academia at the Michael Reese Hospital in Chicago, the University of Missouri, and the University of South Dakota, where his primary area of research was hypertension, heart failure, and the renin-angiotensin system.